论文部分内容阅读
为了准确掌握用药患者地戈辛血药浓度，我们采用放免法对地戈辛血药浓度进行监测，同时测定血清钾、镁浓度，其结果表明：２３．２５％的病人血中地戈辛浓度高于有效治疗浓度，４８．８４％在有效治疗浓度范围内，２７．９１％未达到治疗浓度，此外本组病人中９．３０％出现低血钾，２７．９１％出现低血镁，且低血钾、镁病人产生与服用地戈辛相关的症状，故认为血清中钾、镁浓度对地戈辛治疗效果有一定影响。
In order to get an accurate understanding of the plasma concentration of Gocin in the patients, we monitored the plasma concentration of Goethin by radioimmunoassay and determined the serum potassium and magnesium concentrations. The results showed that the local Gooxin concentration in 23.25% of the patients Higher than the effective treatment concentration, 48.84% in the effective treatment concentration range, 27.91% did not reach the therapeutic concentration, in addition to this group of patients with hypokalemia 9.30%, 27.91% hyponatremia, and Hypokalemia, magnesium patients and taking geoxin-related symptoms, so that the serum potassium and magnesium concentrations on the geoxing treatment has a certain effect.